Alyeska Investment Group’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
Sell
-100,000
Closed -$555K 541
2016
Q2
$555K Buy
+100,000
New +$555K 0.01% 393
2015
Q4
Sell
-78,575
Closed -$614K 498
2015
Q3
$614K Buy
78,575
+7,192
+10% +$56.2K 0.01% 409
2015
Q2
$438K Buy
71,383
+1,155
+2% +$7.09K 0.01% 434
2015
Q1
$566K Sell
70,228
-22,630
-24% -$182K 0.01% 438
2014
Q4
$470K Buy
+92,858
New +$470K 0.01% 423